Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
05/2000
05/11/2000WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
05/11/2000WO2000026167A1 Vitamin d analogues
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025788A1 Inhibitors of prenyl-protein transferase
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases
05/11/2000WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
05/11/2000WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/11/2000WO1999054460A3 Human nucleic acid sequences of normal bladder tissue
05/11/2000WO1999053036A3 Ste20-related protein kinases
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2348703A1 Inhibitors of prenyl-protein transferase
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2317117A1 Ldl related protein and uses thereof
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0999205A1 Aminocycloalkane compounds
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998292A2 Method for inhibiting bone resorption
05/10/2000EP0998285A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
05/10/2000EP0708647B1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor
05/10/2000EP0623019B1 Docosahexaenoic acid based drugs, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain, and preparation processes.
05/10/2000CN1252798A Indazole amide compounds as 5-serotoninergic agents
05/10/2000CN1252722A Use of descarboethoxyloratadine for manfacture of medicament for treatment of urinary incontinence, motion sickness and vertigo
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1052238C Conception promoting 19,11 overbridge estratrene
05/10/2000CN1052218C Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromans
05/10/2000CN1052163C Composition for curing gallstones and kidney stones
05/10/2000CN1052160C Medicinal liquor for curing kidney and urinary system disease and its preparing method
05/09/2000US6060508 Benzylamine derivatives, their preparation and their application in therapeutics
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060479 Quinazoline-4-one AMPA antagonists
05/09/2000US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof
05/09/2000US6060460 Use of betaglycan to reduce scarring
05/09/2000US6060446 Protein and carnosine, glutathione, and/or cyclo-histidine-proline
05/09/2000US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders
05/09/2000CA2151560C Insulin analog formulations
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024780A2 Compositions and methods for treating polycystic kidney disease
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
05/04/2000WO2000024724A1 Thiazole-derivatives
05/04/2000WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/04/2000WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway
05/04/2000WO2000024387A2 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid
05/04/2000WO2000007997A8 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS
05/04/2000WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO2000004862A3 Bioenhanced formulations comprising eprosartan in oral solid dosage form
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000CA2348563A1 Compositions and methods for treating polycystic kidney disease
05/04/2000CA2348529A1 Conductance of improperly folded proteins through the secretory pathway
05/04/2000CA2348165A1 Dihydropyridine compounds and methods of use
05/04/2000CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/03/2000EP0997457A1 3-benzoylindole derivatives and drugs containing the same
05/03/2000EP0996725A1 Human nk-3 related prostate specific gene-1
05/03/2000EP0996618A1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0754043B1 Inhibition of smooth muscle cell migration by (r)-amlodipine
05/03/2000EP0719767B1 Succinamic acid compound, process for producing the same, and use thereof
05/03/2000EP0691985B1 Phosphonomethyldipeptides
05/03/2000EP0563096B1 Novel methylenebisphosphonic acid derivatives
05/03/2000CN1051921C Methods of inhibiting imperfect tissue repair
05/02/2000US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/02/2000US6057432 CysS
05/02/2000US6057349 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxphenyl, and aminophenyl alkylsulfonamides and ureas and their use
05/02/2000US6057321 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
05/02/2000US6057292 Method for inhibiting growth hormone action
05/02/2000CA2022740C Cyclic neurokinin a antagonists
05/02/2000CA2012170C Novel method of ovulation induction in humans
04/2000
04/27/2000WO2000023572A1 Tnfr related gene 12
04/27/2000WO2000023546A1 Method of extracting lipids from marine and aquatic animal tissues
04/27/2000WO2000023451A1 New compounds, their preparation and use
04/27/2000WO2000023445A1 New compounds, their preparation and use
04/27/2000WO2000023436A1 Quinazolinone derivatives
04/27/2000WO2000023425A1 New compounds, their preparation and use
04/27/2000WO2000023417A1 New compounds, their preparation and use
04/27/2000WO2000023416A1 New compounds, their preparation and use
04/27/2000WO2000023415A1 New compounds, their preparation and use
04/27/2000WO2000023113A1 Peptide-based carrier devices for stellate cells
04/27/2000WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders
04/27/2000WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 562